| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003045977A3 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 05/13/2004 | WO2002072073A3 Pharmaceutical formulation comprising atorvastatin calcium |
| 05/13/2004 | WO2002038171A9 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040092749 Polysubstituted idan-1-ol compounds, and methods for their preparation and use |
| 05/13/2004 | US20040092748 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics |
| 05/13/2004 | US20040092597 Fenofibrate compositions having high bioavailability |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092567 Cardiovascular disorders; hypotensive agents |
| 05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092555 Pharmaceutical compositions of a thiazolidinedione derivative and their use as antidiabetics |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092540 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 05/13/2004 | US20040092525 Pirazino(aza)indole derivatives |
| 05/13/2004 | US20040092523 Method for the treatment of heart failure |
| 05/13/2004 | US20040092520 Purine compounds and uses thereof |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092507 Melanocortin receptor agonists |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | US20040092501 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040092495 Hypoglycemic agents; antidiabetic agents |
| 05/13/2004 | US20040092489 Polysubstituted indan-1-ol compounds, and methods for their preparation and use |
| 05/13/2004 | US20040092488 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 05/13/2004 | US20040092473 Method for nucleic acid transfection of cells |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092449 Administering a luminal cholecystokinin releasing factor polypeptide; treating obesity |
| 05/13/2004 | US20040092429 Cardiovascular disorders; antiarrhythmia agents; controlling phosphorylation of cells, tissues |
| 05/13/2004 | US20040091960 Novel physiologically active peptides and use thereof |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091554 Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| 05/13/2004 | US20040091523 Pharmaceutical composition and the process for its preparation |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091453 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs |
| 05/13/2004 | CA2509834A1 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia |
| 05/12/2004 | EP1418228A1 Macroencapsulated secretory cells |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1417351A2 Antisense modulation of apolipoprotein(a) expression |
| 05/12/2004 | EP1417350A2 Antisense modulation of hormone-sensitive lipase expression |
| 05/12/2004 | EP1417320A2 Transgenic plants expressing cobalamin binding proteins |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417199A1 Novel modifications of the trometamol salt of r-thioctic acid and method for producing the same |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417188A1 Novel 2,4-diaminothiazole derivatives |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417174A2 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2004 | EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416966A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 05/12/2004 | EP1416951A1 Melanin-concentrating hormone antagonists |
| 05/12/2004 | EP1416950A1 Artichoke leaf extracts |
| 05/12/2004 | EP1416942A1 Method for treating gout and binding uric acid |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416939A2 Method of treating malignancy associated hypercalcemia using active vitamin d analogues |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1416812A1 Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lipid level |
| 05/12/2004 | EP1303284A4 Compositions and methods for the treatment of skin damage |
| 05/12/2004 | EP1292570B1 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same |
| 05/12/2004 | EP1237856B1 New tri-substituted phenyl derivatives and analogues |
| 05/12/2004 | EP1208095B1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1151756A4 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0871451B1 Composition comprising plant stanol esters and the use thereof for lowering the serum cholesterol |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof |
| 05/12/2004 | CN1496347A Biguanide derivatives |
| 05/12/2004 | CN1496261A Remedies and/or preventives for diabetic ischemic heart diseases |
| 05/12/2004 | CN1496260A Method for increasing leptin levels using nicotinic acid compounds |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |